Differential control of hypoxia-inducible factor 1 activity during pro-inflammatory reactions of human haematopoietic cells of myeloid lineage
Bernhard F. Gibbs, Vadim V. Sumbayev(Medway School of Pharmacy), Rafal Wlodzimierz Wyszynski(Medway School of Pharmacy), Dmitri Pchejetski(University of East Anglia), Inna M. Yasinska(Medway School of Pharmacy)
Cited by 15
Related Papers
Sphingosine Kinase-1 as a Chemotherapy Sensor in Prostate Adenocarcinoma Cell and Mouse Models
|Cancer Research|2005|203
Oxidative Stress–Dependent Sphingosine Kinase-1 Inhibition Mediates Monoamine Oxidase A–Associated Cardiac Cell Apoptosis
|Circulation Research|2006|197
The emerging role of FTY720 (Fingolimod) in cancer treatment
|Oncotarget|2016|174
Overcoming MDR-associated chemoresistance in HL-60 acute myeloid leukemia cells by targeting shingosine kinase-1
|Leukemia|2005|171
The Tim-3-Galectin-9 Pathway and Its Regulatory Mechanisms in Human Breast Cancer
|Frontiers in Immunology|2019|171